Biotech-Turned BNB Treasury Firm Falls 77% After Nasdaq Delisting
Windtree Therapeutics, a biotech company that established a BNB treasury strategy last month, fell 77% on Wednesday after the Nasdaq informed the firm it would be…
Recover your password.
A password will be e-mailed to you.